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Helicobacter pylori, we report here the structure of cell-surface mannans obtained from a virulent strain.
Unlike other wild-type strains, this strain was found to express in good quantities this polysaccharide in
vitro. Structural analysis revealed a branched mannan formed by a backbone of a-(1?6)-linked manno-
pyranosyl residues with approximately 80% branching at the O-2 position. The branches were composed
of O-2-linked Man residues in both a- and b-conﬁgurations:
In addition, this strain also expressed cell-surface emblematic H. pylori lipopolysaccharides (LPS) containing
partially fucosylated polyLacNAc O-chains. Affinity assays with polymyxin-B and concanavalin A revealed
no association between the mannan and the LPS. The described mannans may be implicated in the
mediation of host–microbial interactions and immunological modulation.
 2010 Elsevier Ltd. All rights reserved.1. Introduction
Helicobacter pylori is a widespread Gram-negative bacterium
that colonizes the gastric mucosa of about 50% of the global human
population.1 H. pylori infection is currently recognized to be a cru-
cial event in the induction of gastric malignancies such as gastritis,
gastric atrophy and peptic and duodenal ulcers.2 H. pylori is also di-
rectly correlated with an increased risk of developing gastric can-
cer,3 indeed it is classiﬁed as a type I (deﬁnitive) human
carcinogen.4 So far there is no vaccine available against H. pylori
and control of infection is accomplished by various combinationsll rights reserved.
: +351 234370084.of antibiotic regimes,5 a treatment that is gradually losing effec-
tiveness due to the rise of antibiotic-resistant strains.6 Based on
the proven success of carbohydrate-based vaccines against several
pathogenic bacteria,7 much attention has been drawn towards the
identiﬁcation and structural characterization of H. pylori cell-sur-
face glycans.
Like other Gram-negative bacteria,H. pylori expresses cell-surface
lipopolysaccharides (LPS) that exertmuch inﬂuence in themediation
of host–pathogen interactions, namely, the adhesion to gastric cells
and modulation of the host immune response.8 It is now well estab-
lished that H. pylori LPS comprises three distinct structural domains
constituted by an elongated O-antigenic chain (O-chain), an oligo-
saccharide core and a fatty acid-rich endotoxin moiety, the lipid A
(O-chain?core?lipid A  cell).9 H. pylori O-chains are known to
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structures analogous to some mammalian histo-blood-group anti-
gens, namely, the Lewis (Lea, Leb, Lex, sialyl Lex, Ley) and the blood
groups A and B determinants.9H. pylori serotypesO:3 andO:6 further
present an heptoglycan (D-glycero-a-D-manno-heptoses) domainbe-
tween the Le O-chain and the core region (O-chain?heptogly-
can?core?lipid A cell).9 Also, some strains have shown
elongated a-(1?6)-Glc chains linked to the core11 or, as recently
observed for H. pylori serotype O:2, a chain composed of alternating
O-2- and O-3-linked a-D-glucopyranose residues [?2)-a-D-Glcp-
(1?3)-a-D-Glcp-(1?]n.12
In addition to the LPS, it has been recently demonstrated that H.
pylori bioaccumulates considerable amounts of amylose-like gly-
cans under speciﬁc environmental pressures such as subcultivation
in solid medium.13 The same study points out the existence of ter-
minal, O-2-, O-6- and O-2,6-linked Man residues in the cell-surface
glycan-rich extracts of H. pylori strains NCTC 11637 and clinical
isolates 968 and 14255.13 Furthermore, it was suggested that
growing H. pylori in Ham’s F12 liquid medium enhances the
expression of Man.13 Further suggesting the presence of cell-sur-
face mannose-containing molecules, both H. pylori coccoid and
spiral cellular forms have shown to agglutinate with the a-Man-
speciﬁc lectin of Pisum sativum,14 and coccoid cells have also dem-
onstrated to agglutinate with the a-Man-speciﬁc lectins of Lens
culinaris and Narcissus pseudonarcissus.14 Despite these evidences,
up to now only one report has been presented addressing the
origin and structural organization of H. pylori cell-surface man-
nose-rich polysaccharides (mannans).15 This polysaccharide was
isolated from H. pylori mutant strain NCTC 11637 pgm having a
knock-out of the phosphomannomutase gene and described as
composed of trisaccharide-repeating blocks of terminal, O-2 and
O-2,6 Man residues.15 Silencing of phosphomannomutase was de-
scribed as responsible for the absence of elongated LPS, thus facil-
itating the extraction and puriﬁcation of external glycocalyx
material regarded as yielding Man-rich polysaccharides.15 In this
work, it is reported for the ﬁrst time the expression of mannans
by an H. pylori wild-type strain, H. pylori 968, previously suspected
of expressing this polysaccharide.13
2. Experimental
2.1. Bacterial cultures
H. pylori 968, isolated from a gastric biopsy of a patient diag-
nosed with a peptic ulcer, was provided by the Centre of Biological
Engineering of the University of Minho (Braga, Portugal).2.2. Deﬁnition of virulence proﬁle
H. pylori virulence determinants cytotoxin-associated protein
(cagA) and vacuolating cytotoxin (vacA) encoded by the cagA and
vacA genes were accessed by polymerase chain reaction (PCR). PCR
primers and conditionswere as previously described.16,17 PCR prod-
ucts were visualized by electrophoresis on 2% agarose gels.
2.3. Bacterial growth and purity assessment
H. pylori cells isolated from gastric biopsies by recovery to pre-
warmed Columbia blood Agar (CBA) (bioMérieux, France) and
incubated at 37 C for 72 h on a microaerophilic atmosphere 85%
N2, 10% CO2 and 5% O2). The cells were subcultivated after 48 h
of incubation period with the conditions described above. The cells
were also grown on Ham’s F12-deﬁned liquid medium without the
addition of growth-enhancing factors. The cells were allowed to
grow for 24 h in a glass ﬂask under microaerophilic atmosphereunder gentle stirring at 37 C, as described by Testerman et al.18
Purity assessment was assured by using a highly speciﬁc peptide
nucleic acid probe in a ﬂuorescence in situ hybridization proce-
dure, according to the protocol described by Guimarães et al.19
2.4. Extraction and puriﬁcation of cell-surface glycans
Cell-surface glycans were isolated from the cells using the hot
phenol–water extraction, according to Westphal and Jann.20 The
aqueous layer was dialyzed against distilled water using a
1000 Da cut-off membrane and lyophilized. The resulting material
was fractioned by gel permeation/adsorption chromatography
(GPC) on a polyacrylamide Bio-Gel P-6 (Bio-Rad) (fractionation
range: 1000–6000 Da) as described by Ferreira et al.13
2.5. Sugar composition and linkage analysis
Sugar composition analysis was performed by alditol acetate
method as described by Harris et al.21 The hydrolysis was done
in 4 M triﬂuoroacetic acid (TFA) at 100 C for 3 h, followed by
reduction with NaBH4 and subsequent acetylation with acetic
anhydride in the presence of 1-methylimidazole. Alditol acetate
derivatives were analyzed by gas chromatography–mass spec-
trometry (GC–MS), as described by Ferreira et al.13 Linkage analysis
was carried out by methylation with NaOH/(CH3)2SO/CH3I, as de-
scribed by Ciucanu and Kerek.22
2.6. Afﬁnity chromatography using polymyxin-B
Mannose-richmaterial isolated in the void volume of the Bio-Gel
P6 column was fractionated based on its afﬁnity to polymyxin-B.
Fractionation was performed according to Arafat et al.23 in a poly-
myxin-B–agarose (Sigma Chemical Co.) column with 0.5 cm length
and 0.25 cm diameter, operated at 5 C with a constant ﬂow rate of
0.2 mL min1. The resin was equilibrated with an endotoxin-free
0.1 M ammonium bicarbonate buffer, pH 8.0. Approximately
2.0 mg of samplewas dissolved in the buffer to a ﬁnal concentration
of 0.5 mg mL1 and centrifuged to remove the suspended particles
and the resulting supernatant was loaded into the column. Non-re-
tainedmaterialwas recoveredby elutionwith endotoxin-free buffer
and the retainedmaterial was recovered by elution with 1% sodium
deoxycholate in endotoxin-free buffer solution.
2.7. Afﬁnity chromatography using a Concanavalin-A
Mannose-rich material isolated on the void volume of the Bio-
Gel P6 column was fractionated based on its afﬁnity to the conca-
navalin A lectin. Fractionation was performed on a concanavalin A
(Con A) from Canavalia ensiformis (Jack Bean) agarose conjugate
(Sigma) in a column with 0.5 cm length and 0.25 cm diameter,
operated at 5 C with a constant ﬂow rate of 0.33 mL min1. Prior
to elution the column was pre-washed with a solution composed
of 1 M NaCl, 5 mMMgCl2, 5 mMMnCl2 and 5 mM CaCl2, and equil-
ibrated with a buffer solution of 20 mM Tris 0.5 M NaCl at pH 7.4.
Approximately 2.0 mg of the initial sample was dissolved in the
buffer to a ﬁnal concentration of 1 mg mL1, centrifuged to remove
the suspended particles and the resulting supernatant was loaded
into the column. The non-retained material was recovered by elu-
tion with the buffer and the retained material was recovered in a
stepwise elution using 5 mM, 25 mM and 100 mM of methyl-a-
D-mannopyranoside in buffer solution.
2.8. NMR experiments
1H, 13C and 31P NMR spectra were recorded on a Bruker AMX
600 spectrometer equipped with a TXI probe at 310 K and a Varian
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and recorded at 310 K. Two-dimensional (2D) NMR correlation
spectroscopy (COSY), total correlation spectroscopy (TOCSY), nu-
clear Overhauser effect spectroscopy (NOESY) and heteronuclear
single quantum correlation (HSQC) spectroscopy were performed
using the instrument’s Bruker software. Prior to performing the
NMR experiments, the samples were lyophilized three times with
D2O (99.9%). The HOD peak was used as the internal reference at
dH 4.761 for 1H NMR spectroscopy and orthophosphoric acid (dP
0.0) as the external reference for 31P NMR experiments. Just before
the NMR experiments were carried out, a D2O sample containing
TMS (dH 0.00) was run to aid referencing the HOD signal.
3. Results
H. pylori strain 968 recovered from a gastric biopsy specimen of
a patient with peptic ulcer was characterized by expressing cagA
and vacA (s1,m1), virulence markers that have been directly corre-
lated with the promotion of gastric malignancies.1
3.1. Pre-characterization of H. pylori 968 glycan-rich water
extracts
H. pylori 968 was grown both in CBA solid medium and in Ham’s
F12-deﬁned liquid medium containing no Man. Growth in Ham’s
F12 liquid medium was carried out without the addition of
growth-enhancing factors that could constitute external sources
of polysaccharides. Cell-surface glycans were isolated in the aque-
ous phase resulting from hot phenol–water extraction performed
on intact bacterial cells. The sugar composition of these extracts
is presented in Figure 1 in terms of lg/mg of dry biomass and cor-
responds to the mean value from three independent growth
batches. The results show that CBA glycan-rich extracts were com-
posed mainly of LPS as observed by the considerable amounts of
Gal (2.5 lg/mg), Glc (1.8 lg/mg), GalNAc (1.7 lg/mg) and lower
content of DD-Hep (0.8 lg/mg), LD-Hep (0.7 lg/mg) and Fuc
(0.4 lg/mg). Lower amounts (<1 lg/mg) of Rib, possibly from ribo-
nucleic acids, and Man, as well as trace amounts of Rha and Ara
were also present. Conversely, H. pylori growth in Ham’s F12 liquid
medium (Fig. 1) enhanced the expression of Man by ﬁve times in
relation to CBA, suggesting the expression of mannans. The amount
of Rha (1.5 lg/mg) and Rib (3.3 lg/mg) was also higher in F12. The
amount of LPS sugars (Fuc, Glc, Gal, GlcNAc, DD-Hep and LD-Hep)
was similar to the one observed in CBA, with the exception of
Fuc (0.8 lg/mg) that doubled its concentration denoting an in-
crease in the fucosylation of O-chains.
These results show that F12 liquid medium is more suitable for
mannan expression than CBA. Furthermore, it overcomes contam-0.0
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Figure 1. Sugar composition of H. pylori 968 glycan-rich water extracts resulination with Man from culture medium components present in
CBA. The induction of growth without the addition of enhancing
factors associated with H. pylori high fastidiousness resulted in
very low biomass yields.
3.2. Isolation of a mannan-rich fraction
Linkage analysis (Table 1) showed that H. pylori 968 mannans
recovered from F12 were built by mannopyranosyl residues con-
sisting of terminal (10.3%), O-2-linked (12.0%), O-2,6-linked
(9.0%) units and O-6-linked Man (4.3%). This material also con-
tained O-4-linked Glc (9.6%) from amylose-like glycans13 and O-
3-linked Gal (10.1%) and O-4-linked GlcNAc (8.5%), recognized as
LPS O-chain sugars.9 The similar proportion of O-3-linked Gal and
O-4-linked GlcNAc indicates O-chains exhibiting N-acetyllactos-
amine (LacNAc) moieties [?3)-Gal-(1?4)-GlcNAc-(1?]. Equal
amounts of terminal Fuc (3.4%) and O-3,4-linked GlcNAc (4.0%) res-
idues and the absence of branched Gal residues also suggested the
expression of Type 1 Lea and/or Type 2 Lex blood group determi-
nants.9 The presence of LPS was further conﬁrmed by the identiﬁ-
cation of low percentages of terminal and O-3-linked Glc, O-4-
linked Gal, O-7-linked DD-Hep and O-2-, O-2,7- and O-3,7-linked
ld Hep, normally observed in the core, and O-6-linked GlcNAc from
lipid A.9
The Ham’s F12 Man-rich preparation was subsequently eluted
in a Bio-Gel P6 that removed the bulk of Rha and Rib residues.
The majority of the material (4.0 mg) was recovered in the void
volume and was composed of 30% of sugars, 42% of which corre-
sponding to Man residues.
Linkage analysis on this partially puriﬁed fraction (Table 1) re-
vealed a slightly Man-enrichment mainly due to an increase in
the percentage of O-2-linked Man. Conversely, the overall amounts
of O-4-linked Glc decreased signiﬁcantly, from 10.2% to 3.5%. The
percentage of LPS-assigned sugars remained mostly unchanged
when compared with the non-puriﬁed material.
3.3. NMR studies
The 1H nuclear magnetic resonance (NMR) spectrum of the
Man-rich fraction recovered from the P6 Bio-Gel column (Fig. 2)
exhibited several resonances in the anomeric region d1H 4.9–
5.4 ppm (Table 1). Additionally, 31P NMR (data not shown)
revealed the absence of any phosphorylation in these mannans.
Combined data from 2D 1H–13C HSQC experiments (Fig. 3), link-
age analysis (Table 1) and available literature24–27 resulted in the
assignment of the resonances at d1H/13C 5.31/101.90 (residue A),
5.12/99.71 (residue B) and 5.05/103.20 (residue C), respectively,
to O-2 Man, O-2,6 Man and terminal Man, all in a conﬁguration.Glc Gal GlcNAc DD-Hep LD-Hep
CBA
Ham’s F12 
ting from growth in solid medium (CBA) and Ham’s F12 liquid medium.
Table 1
Linkage proﬁle of the sugars in glycan-rich extracts from the H. pylori 968 non-
puriﬁed material and partially puriﬁed material recovered in the void volume of a
Bio-Gel P6 column
Linkage type Relative molar ratio (%)
Non-puriﬁed Partially puriﬁed
LPS
O-Chain
T-Fuc 3.4 2.8
?6)-Glc 4.2 7.9
T-Gal 1.7 3.4
?3)-Gal 10.1 11.9
T-GlcNAc 1.8 2.5
?4)-GlcNAc 8.5 7.1
?3,4)-GlcNAc 4.0 3.1
Core
*T-Glc 2.8 3.9
?3)-Glc 1.1 2.2
?4)-Gal 5.9 2.6
T-DD-manno-Hep 0.2 v
T-LD-manno-Hep 0.3 v
?2)-DD-manno-Hep 0.5 0.4
?2)-LD-manno-Hep 0.9 0.5
?3)-LD-manno-Hep 0.6 0.4
?7)-DD-manno-Hep 1.0 0.4
?7)-LD-manno-Hep 0.5 0.6
?3,7)-LD-manno-Hep 0.8 0.5
?2,7)-DD-manno-Hep 1.4 0.9
Lipid A
?6)-GlcNAc 0.7 0.3
Mannose-rich glycans
T-Man 10.3 10.8
?2)-Man 12.0 19.2
?6)-Man 4.3 3.8
?2,6)-Man 9.0 9.5
Amylose-like glycans
?4)-Glc 9.6 3.5
?4,6)-Glc 0.6 —
Unassigned sugars
?2)-Ara 0.6 —
?6)-Gal 3.2 2.8
* Terminal Glc residues can be addressed either to amylose-like polymers or to non-
reducing ends of the LPS core. v—vestigial amounts; >0.5% total sugars.
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I
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A
E
C
B
5.4          5.2           5.0 4.8          4.6          4.4     
1H
Figure 2. 1H NMR spectrum of the Man-rich materiaa conﬁguration,24 was also observed. Sequential assignment of
proton signals for spin systems A–D was obtained from the 2D
1H–1H COSY (results not shown) and TOCSY (Fig. 4). The H-6 pro-
tons of O-2,6 Man residues have also been assigned from the HSQC
spectrum (Table 2) based on the characteristic downﬁeld shift of
Man residues at d13C 62.30–68.00 ppm upon substitution at the O-
6 position.24,27 The identiﬁed resonances are summarized in Table
2 and were found to be in accordance with the previous reports.26
Additionally, NOESY experiments (Fig. 5) conﬁrmed the a-conﬁgu-
ration of spin system A assigned to O-2 Man residue by showing a
medium intensity NOE (Nuclear Overhauser Effect) between the
anomeric proton at 5.31 ppm and its H-2 at 4.12 ppm. Residue A
also exhibited a low intensity inter NOE between its H-1 and the
H-2 of residue B at 4.05 ppm demonstrating that O-2-linked Man
are linked to the O-2 position of O-6 Man residues. It further re-
vealed connectivity between the anomeric proton of residue B at
5.12 and its H-6 protons at 3.70 and 3.91 ppm, highlighting the
presence of sequential O-6-linked B residues. The spin-system C
corresponding to terminal Man residues showed a single medium
intensity inner NOE between its anomeric proton at 5.05 ppm
and the H-2 at 4.08 ppm conﬁrming its a conﬁguration. A NOESY
spectrum acquired with a longer mixing time (data not shown),
even though it resulted in strong signal overlapping, allowed the
detection of a very weak connectivity between H-1 and the H-2
of residue A and of residue B. This observation led to the conclusion
that O-2-linked a-Man side chains are terminated by a-Man resi-
dues and that some branches exhibit just one terminal residue.
Combined information from NMR and linkage analysis thus sug-
gest that H. pylori 968 expresses a mannan consisting of a-
(1?6)-linked mannopyranose units with approximately 80% of
O-2-substituted residues. Side chains were found to be composed
of terminal and O-2-linked a-Man residues.
The integration of A–C anomeric resonances in the 1H NMR
spectrum retrieved a proportion of O-2, O-2,6 and terminal Man
of approximately 1:1:1 suggesting the existence of a repetitive unit
in this mannan. However, the proportion between a-Man residues
calculated from the 1H NMR spectrum revealed signiﬁcantly lower
amounts of O-2-linked Man residues than those shown by linkage
analysis (Table 1). A residue E could also be assigned to the reso-
nances at dH1/1C 4.92/101.25 ppm and showed in the TOCSY/HSQC
spectra dH2/C2 at 4.41/79.33 ppm and dH3/C3 at 3.91/71.71 ppm. Fur-
thermore, the NOESY spectrum (Fig. 5) exhibited a strong H-1/H-2
inner and inner NOE and a strong H-1/H-3 inner NOE. These      4.2           4.0       3.8           3.6           3.4       (ppm)
l recovered in the void volume of a P6 column.
Figure 3. Anomeric region of the 2D 1H–13C HSQC spectrum of the Man-rich material recovered in the void volume of a P6 column.
Table 2
1H NMR chemical shifts (ppm) from 2D COSY and 2D TOCSY and 13C chemical shifts from HSQC spectra of Man-rich fraction
Residue H-1/C-1 H-2/C-2 H-3/C-3 H-4/C-4 H-5/C-5 H-6/C-6 Assigned NOE anomeric region
LPS O-chain
a 4.45 3.52 3.68 — — — —
?3)-b-D-Gal 103.03 — —
b 4.65 3.84 — — — — —
?4)-b-D-GlcNAc 102.56 —
Mannose moiety
A 5.31 4.12 3.98 — — — A1 (M); B2 (W)
?2)-a-D-Man 101.99 79.42 71.15
B 5.12 4.05 3.71 3.91 — 3.91, 3.70 B2 (M); B6 (S)
?2,6)-a-D-Man 99.71 — 71.02 72.90 68.00
C 5.05 4.08 3.85 — — 3.90, 3.77 C2 (S); A2 (W)
T-a-D-Man 103.4 — 71.73 62.30
D 4.88 3.98 — — — — —
?6)-a-D-Man — —
E 4.92 4.41 3.91 — — — D2 (S); D3 (S);
?2)-b-D-Man 101.20 79.33 71.70 B2 (VW)
Other structural motifs
I 5.15 3.69 — — — — I2 (S); III6 (S)
Unassigned residue 99.99 70.70 —
II 5.10 4.13 4.00 — — — —
Unassigned residue 108.7 82.41 84.50
III 5.08 3.36 3.62 — — 3.92, 3.68 III2 (M); IV3
?6)-a-D-Glc 99.8 72.71 73.81 — 68.01 (VW)
IV 5.00 4.27 3.86 — — — IV2 (S); IV3 (S)
?3)-a-D-Gal 101.1 70.78 74.20
Legend: S—strong NOE; M—medium NOE; W—weak NOE; VW—very weak NOE.
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chain O-2-linked Man residues in b conﬁguration.28,29 The NOESY
spectrum of residue E highlighted the connectivity between its
anomeric proton and the H-2 of residue B, revealing that some of
the O-6 mannose side chains had O-2-linked b-Man residues.
The NMR studies also showed an array of low intensity signals
from 5.50 to 5.34 ppm assigned to a-Hep from the LPS as well as
O-3- and O-4-linked a-Glc residues and signals at 4.4–4.7 ppmassigned to O-3-linked Gal and O-4-linked GlcNAc residues in b
conﬁguration, characteristic of O-chains.30
Other resonances were observed in the a-anomeric region of
the 1H spectrum (Fig. 1), namely, at 5.15 ppm (residue I) exhibiting
a carbon chemical shift of 99.95 ppm (Fig. 3). However, the ano-
meric region of the COSY and TOCSY (Fig. 2) spectra showed for
this residue a single cross-peak with the H-2 proton at 3.69 ppm.
The strong signal overlapping observed in the ring region
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Figure 4. Anomeric region of the 2D 1H–1H TOCSY spectrum of the Man-rich material recovered in the void volume of a P6 column.
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Figure 5. Anomeric region of the 2D 1H–1H NOESY spectrum of the Man-rich material recovered in the void volume of a P6 column.
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sence of other cross-peaks further compromised its identiﬁcation.
Another unassigned low intensity resonance was detected at
5.10 ppm (residue II in Table 2) and revealed a highly deshielded
C1 chemical shift at 108.7 ppm (data not shown). Two additional
strong resonances were detected at d 5.19 ppm and 5.00 ppm
and assigned, based on its anomeric chemical shifts and linkage
analysis, to a-O-6-linked Glc (residue III) and a-O-3-linked Gal
(residue IV), respectively. Still, the considerable shift upﬁeld exhib-
ited by the H-2 proton of residue O-6 in relation to a linear O-6-
linked structure31 should be pointed out. Additionally, the NOESY
spectrum (Fig. 4) exhibited a cross-peak between the anomericproton of residue I and H-6 protons of residue II at 3.92 ppm and
3.68 ppm conﬁrming both the assignment of residue II to O-6 Glc
and the connectivity between the two residues. It also showed a
weak intra-residue NOE between the H-1 of residue II and the
H-3 of residue III (Table 2) therefore conﬁrming the assignment
of residue III to O-3 Gal and revealing that residue II is linked to
the O-3 position of residue III. In addition, the NOESY also high-
lighted the existence of contiguous O-3-linked a-Gal residues by
showing a strong H-1/H-3 NOE at 5.00/3.85 ppm in addition to
the H-1/H-2 inner NOE at 5.00/4.27 ppm (Fig. 5). Interestingly,
the integration of the anomeric protons of residues I, II and III in
the 1H NMR spectrum (Fig. 2) revealed a proportion of
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linked a-Gal residues, also seen by linkage analysis (Table 2). These
observations thus suggest the following structural motif: a-residue
I-(1?6)-a-D-Glc-(1?3)-a-D-Gal-(1?3)-a-D-Gal-(1?. The experi-
mental proton and carbon chemical shifts recovered from the
COSY, TOCSY and HSQC spectra for residues II and III (Table 2)
matched the theoretical simulation for the oligosaccharide se-
quence ?6)-a-D-Glc-(1?3)-a-D-Gal-(1?3)-a-D-Gal-(1? using
CASPER.28 This calculation revealed a low overall error of
6.38 ppm between the predicted and experimental data further
conﬁrming the mentioned assignment. However, the NOESY spec-
trum revealed no connectivity between the described structural
motif and the mannan moiety or LPS-related signals.
3.4. Evaluation of mannan-LPS associations
Despite being mainly composed of Man residues, the partially
puriﬁed material isolated in the void volume of the Bio-Gel P6 col-
umn also exhibited LPS in its composition. To evaluate the possible
associations between these two domains this fraction, referred as
starting material in Table 3, was fractionated by afﬁnity
chromatography.
3.4.1. Puriﬁcation of mannose-rich glycans using polymyxin-B
The Man-rich material was fractionated according to its ability
to bind to the amphiphilic polypeptide polymyxin-B, an antibiotic
recognized for its afﬁnity for LPS.32 The non-retained fraction (Ta-
ble 3) that corresponded to approximately half of the initial mate-
rial lacked LPS as shown by the absence of Fuc, DD-Hep and LD-Hep
residues. This fraction was composed of 28% of sugars, from which
approximately 50% was Man, and also of lower percentages of Glc
(18%), Gal (17%) and GlcNAc (5%). The isolation of mannans in an
LPS-free fraction suggested that there was no covalent linkage be-
tween these two domains. Conversely, the material recovered from
the column using sodium deoxycholate (Table 3) was mainly com-
posed of LPS (22% Gal, 23% GlcNAc and 4% of Fuc, DD- and LD-Hep).
However, both the 1% and 5% sodium deoxycholate eluted material
also exhibited Man (16–27%). Thus, even though the bulk of the
mannans revealed no afﬁnity to polymyxin-B, a lower percentage
showed afﬁnity to polymyxin-B denoting some amphiphilic
behaviour.
3.4.2. Puriﬁcation of mannose-rich glycans using concanavalin
A
The Man-rich material was also fractionated according to its
afﬁnity to concanavalin A, a lectin recognized to bind to terminal
a-D-mannosyl and a-D-glucosyl33 residues. The non-retainedTable 3
Sugar analysis and protein content of the material resulting from fractionation of the H. p
Fraction Yield (%)
Rha Rib Fuc Ara
Starting material — 1 6 3 1
Polymyxin-B
Non-retained 49 — 14 — —
Retained
1% Sodium deoxycholate 30 — 10 4 —
5% Sodium deoxycholate 4 — 3 3 —
Concanavalin A
Non-retained 39 1 60 2 2
Retained
5 mM Methyl-mannopyranoside 27 — — 4 —
25 mM Methyl-mannopyranoside 19 — — — —
100 mM Methyl-mannopyranoside 17 — — 9 —
v—vestigial amounts; >0.5% total sugars.material was found to be sugar-poor (7% of sugars) and almost
exclusively composed of residual amounts of ribose. The retained
molecules were further recovered in a stepwise elution using
5 mM, 25 mM and 100 mM methyl-a-D-mannopyranoside. The
ﬁrst fraction yielding 27% of the initial material showed a low
abundance of sugars (17%), mainly Man-rich material (39%) but
also LPS (25% Gal, 9% GlcNAc, 4% Fuc, 3% LD-Hep and 2% DD-Hep)
and amylose-like glycans (18% Glc). Conversely, the 25 mM
methyl-a-D-mannopyranoside fraction exhibited the highest sugar
content (45%), 55% of which corresponded to mannans. This frac-
tion lacked LPS, as revealed by the absence of Fuc and core-charac-
teristic Hep residues. Still, it contained 21% Glc, 17% Gal and 7%
GlcNAc. The identiﬁcation of a Man-rich LPS-free fraction further
reinforced the observation made upon polymyxin-B for the lack
of association between these cell-surface glycans. Interestingly,
in both cases, LPS-free mannan-rich material also contained Glc,
Gal and GlcNAc. The results suggest that these sugars might be a
part of the mannan moiety and further structural studies need to
be conducted to conﬁrm this observation.
The remaining material was recovered with 100 mM methyl-a-
D-mannopyranoside and resulted in a fraction containing 32% of
sugars, mainly LPS yielding a high degree of fucosylation (9% of
Fuc). This fraction also contained mannans, even though in much
lower percentage than the previous ones (9%).
3.4.3. Evaluation of linkage pattern of isolated mannans
The linkage pattern of the mannans recovered with 5 mM
methyl-a-mannopyranoside from the concanavalin A column
(Table 4) conﬁrmed a mixture of Man-rich material, LPS and amy-
lose-like glycans previously suggested by sugar analysis (Table 3).
The mannan moiety in this fraction exhibited a mean percentage of
backbone branching of 70%, thus lower than that observed in the
starting material (80%, Table 4). It also showed a much lower per-
centage of O-2-linked Man side chain sugars (8.0%) in relation to
branched residues (11.5% of O-2,6 Man), revealing that some of
the mannan branches contain a single Man residue. Conversely,
the mannans in the 25 mM LPS-free fraction had higher branching
(80%) as a result of an increase in the percentage of O-2,6 Man
residues (22%). Furthermore, they exhibited a lower proportion
of O-2: O-2,6-linked Man (1:2). Additionally, 7–10% of terminal
and O-6-linked Glc and O-3 Gal and lower percentages (<5%) of
O-3 and O-4 Glc, terminal and O-6-linked Gal and terminal and
O-4-linked GlcNAc were also observed. Linkage analysis of the frac-
tion recovered with 100 mM methyl-a-mannopyranoside revealed
LPS exhibiting over 40% of the core material. The O-chains were
composed of LacNAc units (17.3% of O-3 Gal and 8.9% of O-4 Glc-
NAc) and Le blood group determinants as shown by the detectionylori 968 Man-rich on polymyxin-B and concanavalin A columns
Molar ratio (%) Total sugars (%)
Man Glc Gal GlcNAc DD-Hep LD-Hep
42 16 17 11 2 4 29
46 18 17 5 — — 28
27 13 20 22 2 2 35
16 23 22 22 5 6 7
11 2 13 9 1 1 7
39 18 25 9 2 3 17
55 21 17 7 v v 45
9 12 22 28 9 11 32
Table 4
Linkage proﬁle of the sugars observed in H. pylori 968 fractions showing afﬁnity to
concanavalin A
Linkage type Relative molar ratio (%)
[Methyl-a-D-mannopyranoside]
5 mM 25 mM 100 mM
LPS
O-chain
T-Fuc 3.0 — 7.0
?6)-Glc 9.0 — 2.4
T-Gal 1.9 — 3.5
?3)-Gal 10.7 — 17.3
T-GlcNAc 0.3 — 4.5
?4)-GlcNAc 5.0 — 8.9
?3,4)-GlcNAc 1.5 — 5.4
Core
*T-Glc 6.2 — 5.8
?3)-Glc 1.1 — 4.6
?4)-Gal 6.3 — 4.8
T-DD-manno-Hep v — 0.7
T-LD-manno-Hep v — 0.9
?2)-DD-manno-Hep 0.3 — 1.2
?2)-LD-manno-Hep 0.9 — 6.0
?3)-LD-manno-Hep 0.6 — 2.8
?7)-DD-manno-Hep 0.9 — 3.9
?7)-LD-manno-Hep 0.8 — 2.9
?3,7)-LD-manno-Hep 0.8 — 2.2
?2,7)-DD-manno-Hep 1.2 — 2.5
Lipid A
?6)-GlcNAc 1.0 — —
Mannose-rich glycans
T-Man 11.4 22.4 1.4
?2)-Man 8.0 10.2 10.9
?6)-Man 4.8 5.1 —
?2,6)-Man 11.5 21.6 1.2
Amylose-like glycans
T-Glc* — 9.1 —
?4)-Glc 8.1 4.2 0.3
?4,6)-Glc — — —
Unassigned sugars
?3)-Glc — 2.5 —
?6)-Glc — 6.8 —
T-Gal 2.3
?4)-Gal — 0.8 —
?3)-Gal — 10.1 —
?6)-Gal 4.7 2.0 —
T-GlcNAc — 1.5 —
?4)-GlcNAc — 1.4 —
* Terminal Glc residues can be addressed either to amylose-like polymers or to
non-reducing ends of the LPS core. v—vestigial amounts; >0.5% total sugars.
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Contrasting with other fractions, the mannan moiety in this one
did not exceed 15% of the total sugars and was mainly composed
of O-2-linked Man (80% of the total Man). Furthermore, no O-6-
linked residues were detected revealing a totally substituted poly-
saccharide with elongated side chains.
The structural diversity observed for the mannan moiety
throughout the three studied fractions revealed the absence of a
structure formed by repeating blocks but rather a random organi-
zation showing different branching degrees and side chain exten-
sions and even substitution.
4. Discussion
The expression of vestigial amounts of Man at H. pylori cell sur-
face has been long postulated14,34 and found widespread among
several strains.13,14,34 Furthermore, we have observed that some
fresh clinical isolates express high amounts of Man. Still, after very
few subcultivations in vitro, Man expression decreased to residual
levels (<5% of the cell-surface sugars). As a result of its low biolog-ical abundance structural assignment of H. pylori cell-surface Man
has remained a difﬁcult task. However, the previous studies have
highlighted that H. pylori wild-type virulent strain 968 over-ex-
pressed Man, even after successive subcultivation in CBA.13
In an attempt to further potentiate the expression of mannans,
this strain was grown in Ham’s F12 liquid medium, known by its
capability to overcome H. pylori high fastidiousness.35 H. pylori
cells recovered from F12 had an enhanced mannan expression
when compared with the ones recovered from solid medium. This
was most likely a result of pH decrease from 6.5 to approximately
5.0, a consequence of continuous sparging of the medium with CO2
during growth. Such pH variations have been described to exert
strong inﬂuence in gene expression and modulation of the activity
of the enzymes related with the biosynthesis of GDP-D-Man.36,37 In
H. pylori, GDP-D-Man is mainly produced from D-fructose-6-phos-
phate in a three-step pathway36,38,39 and the ﬁrst and third steps
are catalyzed by a bifunctional phosphomannose isomerase/GDP-
D-mannose phosphorylase, an enzyme found only in bacteria and
involved in the expression of capsular polysaccharides.38 GDP-D-
Man is the main precursor of GDP-L-Fuc used by H. pylori in the
fucosylation of LPS O-chains39 using a pathway with three addi-
tional steps.39 A decrease in pH from 6.5 to 5.0 has been recognized
to enhance the expression of the wbcJ gene, encoding a protein
homologue involved in the conversion of GDP-Man to GDP-Fuc.36
Thus, pH conditions encountered in H. pylori 968 culture medium
may be considered to favour the fucosylation of LPS O-chains.
However, the enzymes involved in the conversion of GDP-D-Man
into GDP-L-Fuc have been described to have optimal pH activities
at 6.5 and 8.0, respectively,37 contributing to an increase in the
pool of GDP-D-Man residues available for the production of Man-
rich glycans. It should also be pointed out that GDP-D-Man is also
the precursor of other activated nucleotides, namely, GDP-6-
deoxy-D-talose and GDP-D-Rha,39 thus explaining the presence of
Rha in glycan-rich water extracts.
The mannans at H. pylori 968 cell surface were found co-ex-
pressed with LPS with O-chains carrying LacNAc units and Le blood
group determinants. NMR structural studies demonstrated that H.
pylori 968 mannans are formed by a sugar backbone of a-(1?6)-
linked mannopyranose units exhibiting an average branching of
80% at the O-2 position and side chains composed of O-2-linked
residues. Interestingly, the O-2 side chain residues were found to
be either in a- or in b-anomeric conﬁguration. Similar mannans
have been observed in cell surface of several other microorgan-
isms, namely, in the cell wall of yeasts,26,29,40 and fungi,25 or in
the form of phosphorylated mannans and arabinomannans in
mycobacteria.41 They have further been detected at the cell surface
of Gram-positive bacteria,27,42 as well as in exopolysaccharides
from Gram-negative Pseudomonas syringae pv. ciccaronei24 and Por-
phyromonas gingivalis.43 However, some structural variability was
observed mainly in the percentage of branching of the backbone
and substitution pattern of its side chains. Mannan side chains
similar to the ones of H. pylori 968, exhibiting both terminal and/
or O-2-linked Man in a and/or b conﬁgurations have also been de-
scribed in yeasts29 and Gram-positive27 bacteria. Moreover, the
microorganism mannans may present O-3-linked Man, terminal
Glc,24 and a-Ara27,41 as side chains. The structural diversity ob-
served may be thought to also occur in H. pylori 968 where consid-
erable amounts of unassigned terminal and O-6-Glc and O-3-Gal
were systematically found in Man-rich extracts.
Alpha mannans were also found as O-chains in the LPS of Gram-
negative enterobacteria Hafnia alvei strain PCM 1223,44 Citrobacter
braakii,45 Escherichia coli serotype O8,46 and O947 and Klebsiella
pneumoniae serotype O5.46 However, in the mentioned cases, the
mannan backbone was formed by O-2- and O-3-linked Man resi-
dues whereas in H. pylori 968 the backbone is formed by O-6-
and O-2,6-linked Man.
838 J. A. Ferreira et al. / Carbohydrate Research 345 (2010) 830–838H. pylori cell-surface mannans seem to be directly involved in
the mediation of host–microbial interactions and immunological
modulation. In agreement with these considerations, the data have
been presented that H. pylori cells can interact with the mannose-
binding lectin (MBL) protein,48 coded by the MBL-2 human gene, a
key component in systemic and mucosal innate immunity.49–51
MBL was found to induce bacterial elimination52,53 by activating
the complement system and to promote complement-independent
opsonophagocytosis.54 Besides activating local immune responses
against the bacteria, the interaction between H. pylori mannans
and the MBL protein may also exert much inﬂuence in the clinical
outcome resulting from infection.
H. pylori mannans may also have an antigenic potential result-
ing from their capability to trigger immune responses48 making
them potential candidates to include in a carbohydrate-based vac-
cine. Furthermore, they overcome some of the limitations shown
by other glycans found in H. pylori cell surface, namely, amylose-
like polysaccharides widespread through nature and LPS O-chains
recognized to express mammalian Lewis histo-blood group
determinants.
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